Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters










Publication year range
1.
Arq. bras. med. vet. zootec. (Online) ; 72(5): 1599-1608, Sept.-Oct. 2020. tab, graf, ilus
Article in Portuguese | LILACS, VETINDEX | ID: biblio-1131555

ABSTRACT

A doença periodontal é uma afecção comum, relacionada ao aprisionamento de alimentos em diastemas não fisiológicos, em equinos. O tratamento consiste na correção da causa primária, limpeza e desbridamento do sulco gengival, denominado tratamento convencional (TC). Frequentemente antimicrobianos são necessários, pela gravidade ou patogenicidade dos agentes. A terapia fotodinâmica adjuvante (TF) tem sido estudada pelo seu potencial combate bacteriano, sem causar resistência bacteriana. O objetivo deste estudo foi analisar o uso da TF na doença periodontal, experimentalmente induzida, em dentes incisivos de equinos, e compará-la com o TC. O TC não resultou em melhora clínica estatisticamente, tanto em graus como em profundidade, apenas numérica na profundidade aos 30 dias. A TF foi empregada em dentes com profundidade maior da bolsa periodontal que a do grupo TC e, mesmo assim, apresentou melhora clínica já com sete dias, e mais efetiva aos 30, atingindo, em média, o valor considerado normal, três milímetros. A TF apresentou potencial para ser aplicada na rotina, pelo incremento nos resultados, sem causar efeitos colaterais.(AU)


Periodontal disease is a common condition, related to the entrapment of food in non-physiological diastemas in horses. Treatment consists of correction of the primary cause, cleansing and debridement of the gingival sulcus, called Conventional Therapy (CT). Often antimicrobials are requested due to the severity or pathogenicity of the agents. Adjuvant Photodynamic Therapy (PDT), has been studied for its potential bacterial combat, without causing bacterial resistance. The objective of this study was to analyze the use PDT with the experimentally induced periodontal disease in the incisor teeth of horses, and to compare with the CT. The CT did not result in clinical improvement, either in degrees or millimeters. The PDT was used in teeth with a greater depth of the periodontal pocket than the TC group, and even then, showed clinical improvement in only seven days, and more effective at 30, reaching the three millimeter value considered normal on average. The PDT presented the potential to be applied in the routine by the increase in the results without causing side effects.(AU)


Subject(s)
Animals , Periodontal Diseases/therapy , Periodontitis/veterinary , Diastema/therapy , Horses , Photochemotherapy/veterinary
2.
Article in English | LILACS | ID: lil-560252

ABSTRACT

Pharmaceutical formulations containing poloxamer 407 (P407), Carbopol 934P (C934P) or gelatin (GELA), with ethanolic propolis extract (PE), were designed for the treatment of oral mucosal diseases. PE was produced and its quality was assessed by measuring its specific gravity, pH, weight of dry residue and total flavonoid content. Monopolymeric and binary polymeric formulations were prepared and their gelling temperature (Tsol/gel), pH, continuous flow rheology and mucoadhesion were studied. PE exhibited good quality and the formulations were easy to prepare and showed a wide range of consistency. Most of the formulations showed thermoresponsive behaviour and only those containing 15% P407, plus 0.20% C934P or 1.0 % GELA, displayed Tsol/gel suitable for application to the oral mucosa. Monopolymeric formulations, containing C934P or GELA, and binary formulations exhibited pseudoplastic flow and low degrees of thixotropy. Monopolymeric formulations containing P407 exhibited pseudoplastic flow and rheopexy. The mucoadhesive properties of the systems could not be assessed. Fragments of formulation were found to remain stuck to parts of the mucin disc, owing to cohesive failure of the samples and of the sample/mucin interface. The data obtained on these formulations indicate a potentially useful role in the treatment of oral mucosal diseases


Formulações farmacêuticas contendo poloxamer 407 (P407), Carbopol 934P (C934P) ou gelatina (GELA), e extrato de própolis (EP) foram desenvolvidos para o tratamento de doenças da mucosa oral. EP foi produzido e sua qualidade foi avaliada quanto ao resíduo seco e ao teor de flavonóides totais. Formulações monopoliméricas e poliméricas binárias foram produzidas e a temperatura de gelificação (Tsol/gel), o pH, a reologia, assim como a mucoadesão das mesmas foram avaliados. O EP apresentou boa qualidade, as preparações foram fáceis de produzir e apresentaram uma ampla variação de consistência. A maioria das preparações apresentou comportamento de resposta térmica e apenas as formulações contendo 15% P407 e 0,20% C934P ou 1,0% GELA apresentaram Tsol/gel adequada para a administração na mucosa oral. Formulações monopoliméricas, contendo C934P ou GELA, e binárias exibiram comportamento de fluxo pseudoplástico e baixo grau de tixotropia. Formulações monopoliméricas de P407 exibiram fluxo pseudoplástico e reopexia. As propriedades mucoadesivas dos sistemas não puderam ser avaliadas. Fragmentos de formulações foram encontrados aderidos em alguns lugares do disco de mucina devido à falha de coesão das amostras e da interface amostra/mucina. Os resultados obtidos com essas formulações indicam a utilidade das mesmas no tratamento de doenças da mucosa oral.


Subject(s)
Humans , Mouth Mucosa , Pharmaceutical Preparations , Propolis
3.
Article in Portuguese | LILACS | ID: lil-549767

ABSTRACT

Observa-se na Fitoterapia uma tendência de contribuição efetiva à saúde da população. Por consequência, a padronização de fitomedicamentos é um pré-requisito para a garantia da qualidade, bem como para a constância dos efeitos terapêuticos e segurança do usuário. A validação de processo analítico deve garantir, através de evidências experimentais, que o método atenda às exigências das aplicações analíticas, assegurando a confiabilidade dos resultados. Assim, os equipamentos e materiais de laboratório devem ser devidamente calibrados e o analista qualificado. As substâncias químicas de referência devem ser certificadas por compêndios oficiais, como as Farmacopeias ou por outros códigos autorizados pela legislação vigente. Tão importante quanto o desenvolvimento e validação de uma metodologia analítica é o posterior estudo de estabilidade, a fim de garantir que o produto mantenha sua qualidade durante toda vida útil. Para a obtenção de registro de um medicamento fitoterápico dentro dos padrões requeridos pela legislação faz-se necessário, portanto, a realização de diferentes testes para validação deste medicamento de forma a garantir sua segurança no uso, eficácia na utilização e qualidade do produto.


There is an observable trend towards phytotherapy making a recognized effective contribution to public health. Consequently, the standardization of phytomedicines is a prerequisite for quality assurance and to ensure the consistency of therapeutic effects and safety of the user. Analytical method validation should ensure, through experimental testing, that the method meets the requirements of the analytical applications, ensuring the reliability of results. Thus, the equipment and laboratory materials must be properly calibrated and the analyst qualified. The chemical references must be certified by official compendia, such as pharmacopoeias or other officially accepted codes. As important as the development and validation of an analytical methodology is the stability study, performed to ensure that the product retains its quality throughout its shelf-life. Therefore, to register a herbal medicine in accordance with the legal standards, it is necessary to carry out various validation tests on the product, to ensure its safety, effectiveness and quality.


Subject(s)
Phytotherapy/standards , Phytotherapeutic Drugs , Plants, Medicinal
4.
Rev. ciênc. farm. básica apl ; 29(2): 129-134, 2008. tab, ilus, graf
Article in English | LILACS | ID: lil-514281

ABSTRACT

Ethylcellulose microparticles containing propolis ethanolic extract (PE) were prepared by the emulsification and solvent evaporation method. Three ratios of ethylcellulose to PE dry residue value (DR) weretested (1:0.25, 1:4 and 1:10). Moreover, polysorbate 80 was used as emulsifier in the external phase (1.0 or 1.5% w/w). Regular particle morphology without amorphous and/or sticking characteristics was achieved only when an ethylcellulose: DR ratio of 1:0.25 and 1.0% polysorbate 80 were used. Microparticles had a mean diameter of 85.83 mium. The entrapment efficiency forpropolis of the microparticles was 62.99 more or less 0.52%. These ethylcellulose microparticles containing propolis would be useful for developing propolis aqueous dosage forms without the strong and unpleasant taste, aromatic odour and high ethanol concentration of PE.


Subject(s)
Ethanol/analogs & derivatives , Propolis/analogs & derivatives , Pharmaceutical Preparations , Polysorbates
5.
Drug Dev Ind Pharm ; 32(2): 229-38, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16537203

ABSTRACT

Gelatin microparticles containing propolis ethanolic extractive solution were prepared by spray-drying technique. Particles with regular morphology, mean diameter ranging of 2.27 microm to 2.48 microm, and good entrapment efficiency for propolis were obtained. The in vitro antimicrobial activity of microparticles was evaluated against microorganisms of oral importance (Enterococcus faecalis, Streptococcus salivarius, Streptococcus sanguinis, Streptococcus mitis, Streptococcus mutans, Streptococcus sobrinus, Candida albicans, and Lactobacillus casei). The utilized techniques were diffusion in agar and determination of minimum inhibitory concentration. The choice of the method to evaluate the antimicrobial activity of microparticles showed be very important. The microparticles displayed activity against all tested strains of similar way to the propolis, showing greater activity against the strains of E. salivarius, S. sanguinis, S. mitis, and C. albicans.


Subject(s)
Anti-Infective Agents/administration & dosage , Anti-Infective Agents/therapeutic use , Gelatin/chemistry , Propolis/administration & dosage , Propolis/therapeutic use , Candida albicans/drug effects , Drug Carriers , Ethanol/chemistry , Lacticaseibacillus casei/drug effects , Microbial Sensitivity Tests , Particle Size , Streptococcaceae/drug effects
6.
Rev. ciênc. farm ; 25(2): 79-84, 2004. ilus
Article in English | LILACS | ID: lil-418895

ABSTRACT

The purpose of this study was to investigative the in vitro release of propolis from gelatin microparticles. Gelatin microparticles containing porpolis extractive solution (PES) were prepared by spray-drying technique. Microparticles with a mean diameter of 2.50 µm and with regular morphology were obtained. The entrapment efficiency of propolis in the microparticles was over 39%. Spray-drying showed to be a feasible method for the preparation of gelatin microparticles containing propolis. Comparing to PES, the in vitro release of propolis from gelatin microparticles in aqueous medium was slower, considering markes 1 and 2. Thus, it was possible to transform a liquid propolis dosage form into a solid one, improving manipulation, packaging and storage and with modified release in aqueous medium, comparatively to the ethanolic extract of the drug


Subject(s)
Drug Compounding/methods , Gelatin , In Vitro Techniques , Propolis
7.
Int J Pharm ; 264(1-2): 45-55, 2003 Oct 02.
Article in English | MEDLINE | ID: mdl-12972335

ABSTRACT

Gelatin microparticles containing propolis extractive solution (PES) were prepared by spray-drying technique. The optimization of the spray-drying operating conditions and the proportions of gelatin and mannitol were investigated. Regular particle morphology was obtained when mannitol was used, whereas mannitol absence produced a substantial number of coalesced and agglomerated microparticles. Microparticles had a mean diameter of 2.70 microm without mannitol and 2.50 microm with mannitol. The entrapment efficiency for propolis of the microparticles was upto 41% without mannitol and 39% with mannitol. The microencapsulation by spray-drying technique maintained the activity of propolis against Staphylococcus aureus. These gelatin microparticles containing propolis would be useful for developing intermediary or eventual propolis dosage form without the PES' strong and unpleasant taste, aromatic odour, and presence of ethanol.


Subject(s)
Gelatin/chemistry , Propolis/chemistry , Chromatography, High Pressure Liquid , Drug Carriers , Drug Compounding , Mannitol , Microscopy, Electron, Scanning , Particle Size , Propolis/pharmacology , Staphylococcus aureus/drug effects
8.
Rev. bras. farmacogn ; 9/10(1): 1-10, 2000. ilus
Article in Portuguese | LILACS | ID: lil-534790

ABSTRACT

Os autores propõem procedimentos para estabelecer o controle de qualidade da própolis. Para tanto, foram adaptadas e executadas técnicas farmacopéicas e/ou desenvolvidas técnicas novas. Foram estabelecidos perfis dos teores de flavonóides, de ceras, de substâncias voláteis totais (através da perda por dessecação) e de cinzas totais. Os valores obtidos para as amostras de própolis estudadas, coletadas em um apiário-escola, foram comparados com os de própolis adquiridas no mercado. Foi estabelecido, ainda, o perfil destes parâmetros para amostras de própolis coletadas nos diferentes locais da colméla, no periodo de três anos, com coletas de inverno e verão. Os teores de flavonóides variaram entre 2,05 - 5,52 por cento.


The aim of this work was to establish a control quality methodology for propolis. For that, techniques were carried out as described in pharmacopoeias, or adapt from it. Moreover it developed new techniques. It was used propolis collected in the school apiary. Profiles of flavonoids, waxes, total volatile substances and total ashes were determined in propolis collected in different places of bees' hive. The results obtained from this propolis were compared with commercial propolis. Flavonoid drift values obtained from apiary school were established in the range between 2.05-5.52 percent.

9.
FEBS Lett ; 238(1): 171-4, 1988 Sep 26.
Article in English | MEDLINE | ID: mdl-2844593

ABSTRACT

Incubation of trifluoperazine, a local anaesthetic, at concentrations higher than the cmc with Sendai virus particles produces the selective solubilization of the haemagglutinin neuraminidase (HN) and matrix (M) proteins. This phenomenon involves aggregation of the Sendai virions and therefore the separation of HN and M from the rest of the particle can be performed by bench centrifugation. The supernatant contains the HN and M proteins and HN, once inserted into liposomes, elicits its own biological activities. Therefore, the method seems suitable for purifying large amounts of HN.


Subject(s)
Hemagglutinins, Viral/isolation & purification , Parainfluenza Virus 1, Human/analysis , Viral Matrix Proteins/isolation & purification , Virion/analysis , Animals , Chick Embryo , Detergents , Neuraminidase/isolation & purification , Parainfluenza Virus 1, Human/enzymology , Solubility , Trifluoperazine , Virion/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL
...